6ZCJ
14-3-3sigma in complex with SLP76pS376 phosphopeptide crystal structure
Summary for 6ZCJ
Entry DOI | 10.2210/pdb6zcj/pdb |
Descriptor | 14-3-3 protein sigma, SLP76pS376, MAGNESIUM ION, ... (4 entities in total) |
Functional Keywords | adaptor protein, phosphorylation, peptide binding protein |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 2 |
Total formula weight | 27850.65 |
Authors | Soini, L.,Leysen, S.,Davis, J.,Ottmann, C. (deposition date: 2020-06-11, release date: 2020-12-02, Last modification date: 2024-11-20) |
Primary citation | Soini, L.,Leysen, S.,Davis, J.,Westwood, M.,Ottmann, C. The 14-3-3/SLP76 protein-protein interaction in T-cell receptor signalling: a structural and biophysical characterization. Febs Lett., 595:404-414, 2021 Cited by PubMed Abstract: The SH2 domain-containing protein of 76 kDa, SLP76, is an important adaptor protein that coordinates a complex protein network downstream of T-cell receptors (TCR), ultimately regulating the immune response. Upon phosphorylation on Ser376, SLP76 interacts with 14-3-3 adaptor proteins, which leads to its proteolytic degradation. This provides a negative feedback mechanism by which TCR signalling can be controlled. To gain insight into the 14-3-3/SLP76 protein-protein interaction (PPI), we have determined a high-resolution crystal structure of a SLP76 synthetic peptide containing Ser376 with 14-3-3σ. We then characterized its binding to 14-3-3 proteins biophysically by means of fluorescence polarization and isothermal titration calorimetry. Furthermore, we generated two recombinant SLP76 protein constructs and characterized their binding to 14-3-3. Our work lays the foundation for drug design efforts aimed at targeting the 14-3-3/SLP76 interaction and, thereby, TCR signalling. PubMed: 33159816DOI: 10.1002/1873-3468.13993 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.53 Å) |
Structure validation
Download full validation report
